Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Phase Therapeutic range Weeks 13-16 Weekly Dose 9 mg Notes Step to 9 mg or hold at 6 mg
Consequently, therapeutic targeting of aberrant PI3K/AKT activation in this context has focused on pathway switch-off (Vanhaesebroeck et al, 2021)
Improves Energy and Cellular Health When cells are stressed, energy production slows
If off-label use for PCOS is not an approved use, encourage your employees to discuss alternative treatment options with their provider
Not Suitable For: The treatment is not suitable for: Pregnant or Breastfeeding Individuals: Due to potential risks to the foetus or breastfeeding infant
US$ 28.07
US$ 28.04
US$ 22.44
US$ 23.70
)
